Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Evens

Showing results (11-20 of 253) with videos related to

Pageof 26
Sort By:
Current Opinion in Oncology|May 25, 2006
Targeting angiogenesis for the treatment of sarcomaLakshmi Balasubramanian, Andrew M Evens
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
How can outcomes be improved for older patients with Hodgkin lymphoma?Andrew M Evens, Fangxin Hong
Clinical Advances in Hematology & Oncology : H&O|July 8, 2014
FDG-PET imaging for Hodgkin lymphoma: current use and future applicationsLale Kostakoglu, Andrew M Evens
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2020
Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and MortalityAndrew M Evens, Susan K Parsons
Ejhaem|November 29, 2023
Lymphoma in adolescents and young adults: Navigating a path forward togetherAndrew M Evens, Kara M Kelly
Clinical Lymphoma|October 23, 2004
Radioimmunotherapy in non-Hodgkin's lymphoma: trials of yttrium 90-labeled ibritumomab tiuxetan and beyondAndrew M Evens, Leo I Gordon
Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
Molecular etiology of mature T-cell non-Hodgkin's lymphomasAndrew M Evens, Ronald B Gartenhaus
Current Treatment Options in Oncology|July 6, 2004
Treatment of T-cell non-Hodgkin's lymphomaAndrew M Evens, Ronald B Gartenhaus
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Oxidative stress and apoptosis: a new treatment paradigm in cancerRyan H Engel, Andrew M Evens
Current Treatment Options in Oncology|June 21, 2002
Burkitt's and Burkitt-like lymphomaAndrew M Evens, Leo I Gordon
Pageof 26

Showing results (11-20 of 253) with videos related to

Sort By:
Pageof 26
Current Opinion in Oncology|May 25, 2006
Targeting angiogenesis for the treatment of sarcomaLakshmi Balasubramanian, Andrew M Evens
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
How can outcomes be improved for older patients with Hodgkin lymphoma?Andrew M Evens, Fangxin Hong
Clinical Advances in Hematology & Oncology : H&O|July 8, 2014
FDG-PET imaging for Hodgkin lymphoma: current use and future applicationsLale Kostakoglu, Andrew M Evens
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2020
Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and MortalityAndrew M Evens, Susan K Parsons
Ejhaem|November 29, 2023
Lymphoma in adolescents and young adults: Navigating a path forward togetherAndrew M Evens, Kara M Kelly
Clinical Lymphoma|October 23, 2004
Radioimmunotherapy in non-Hodgkin's lymphoma: trials of yttrium 90-labeled ibritumomab tiuxetan and beyondAndrew M Evens, Leo I Gordon
Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
Molecular etiology of mature T-cell non-Hodgkin's lymphomasAndrew M Evens, Ronald B Gartenhaus
Current Treatment Options in Oncology|July 6, 2004
Treatment of T-cell non-Hodgkin's lymphomaAndrew M Evens, Ronald B Gartenhaus
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Oxidative stress and apoptosis: a new treatment paradigm in cancerRyan H Engel, Andrew M Evens
Current Treatment Options in Oncology|June 21, 2002
Burkitt's and Burkitt-like lymphomaAndrew M Evens, Leo I Gordon
Pageof 26